NCT02752932View on ClinicalTrials.gov

TumorGraft- Guided Therapy for Improved Outcomes in Head and Neck Squamous Cell Cancer- A Feasibility Study

NACompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

October 12, 2017

Study Completion Date

October 12, 2017

Conditions
Head and Neck Squamous Cell Carcinoma
Interventions
OTHER

Drug testing on PDX per Investigator's choice (upto 4)

Drug of Investigator's choice (upto 4 Ontario funded Chemotherapeutics) will be tested on PDX (Patient Derived Xenografts)

Trial Locations (1)

N6A 4L6

London Regional Cancer Program, London

Sponsors

Collaborators (1)

Champions Oncology
All Listed Sponsors
collaborator

Champions Oncology

INDUSTRY

lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER